CytoDyn Inc.
CYDY- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001175680
No open-market purchases or sales by CytoDyn Inc. insiders were filed in the last 90 days; 6 institutions reported holding it in 13F filings for Q2 2026, worth $35.2K in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding CytoDyn Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 11 | 11 | 0 |
| Shares | 323.9K | 439.4K | +115.5K (+35.6%) |
| Value | $76.4K | $120.5K | +$44.0K (+57.6%) |
New holders (1)
Institutions that held CytoDyn Inc. at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| NBC Securities, Inc. | 160,000 | $41.6K | 0.00% |
Sold out (1)
Institutions that held CytoDyn Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| ORG Partners LLC | 54,600 | $3.06K |